EDMONTON, Alberta & CALGARY, Alberta–Nanostics. Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, and OncoHelix a leader in precision diagnostics, today announced their partnership to provide ClarityDX Prostate® to healthcare providers and men in the Middle East. OncoHelix provides advanced molecular diagnostics and immune profile testing to the…
↧